| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 4 | |
| #2 | EPO (European Patent Office) | 2 | |
| #3 | United States | 2 | |
| #4 | Canada | 1 | |
| #5 | Singapore | 1 | |
| #6 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals | |
| #3 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Microorganisms | |
| #2 | Medical preparations | |
| #3 | Peptides | |
| #4 | Therapeutic chemical compounds | |
| #5 | Unspecified technologies | |
| #6 | Measuring microorganism processes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Anderson David Andrew | 5 |
| #2 | Li Fan | 5 |
| #3 | Purcell Damian Francis John | 3 |
| #4 | Hui Zhuang | 2 |
| #5 | Torresi Joseph | 2 |
| #6 | Learmont Jennifer Catherine | 1 |
| #7 | Azad Ahmed Abdullah | 1 |
| #8 | Mak Johnson Chung-Shun | 1 |
| #9 | Crowe Suzanne | 1 |
| #10 | Mcphee D A | 1 |
| Publication | Filing date | Title |
|---|---|---|
| AU4394101A | A nucleic acid construct encoding a processing component derived from the n-terminal region of the hepatitis virus ORF2, and an antigenic polypeptide | |
| AUPQ927600A0 | A method of prophylaxis, treatment and diagnosis | |
| AUPQ927500A0 | A method of prophylaxis, treatment and diagnosis | |
| AUPQ661600A0 | A nucleic acid construct and methods related thereto | |
| EP0754223A1 | Non-pathogenic strains of hiv-1 | |
| EP0717752A1 | Therapeutic compounds |